Drug intelligence / Profile preview

budesonide + triamcinolone

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Oral, Rectal, Intranasal, Topical, Ophthalmic, Intraarticular, Intramuscular
01

Overview

Budesonide + triamcinolone is a combination of two synthetic corticosteroids, each with potent anti-inflammatory and immunosuppressive properties. Budesonide is primarily used to treat inflammatory diseases affecting the airways and gastrointestinal tract, such as asthma, COPD, Crohn's disease, and ulcerative colitis[1][3][6]. Triamcinolone is used for a wide range of inflammatory conditions including allergic disorders, arthritis, skin diseases, ocular inflammation, and certain autoimmune conditions[4][8]. Both drugs act by binding to the glucocorticoid receptor and modulating gene expression to suppress pro-inflammatory cytokines and mediators. The combination would theoretically provide additive or synergistic anti-inflammatory effects but is not a standard or widely marketed fixed-dose product.

02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on budesonide + triamcinolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on budesonide + triamcinolone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call